Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Independent opinions of independent directors on relevant matters of the company
In accordance with the company law of the people’s Republic of China, the guiding opinions on the establishment of independent director system in listed companies, the stock listing rules of Shenzhen Stock Exchange, the guidelines for the standardized operation of listed companies, the articles of association of Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) and other relevant provisions, as an Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) independent director, he promised to perform his duties independently and was not affected by the company’s major shareholders For the influence of the actual controller or the units or individuals having interests with the company and its major shareholders and actual controllers, after carefully reviewing the relevant materials, they express their independent opinions as follows:
1、 Independent opinions on the appointment of financial director
After reviewing Ms. Kong Yun’s resume and other materials, it is not found that she is not allowed to serve as a senior manager of the company as stipulated in Article 146 of the company law and article 3.2.3 of the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange, nor is she confirmed as a market prohibited person by the CSRC and the prohibition has not been lifted; He / she meets the qualifications and qualifications of senior managers as stipulated in the company law and the articles of association, and is competent for the duties of the post he / she is employed. The nomination and appointment procedures of the board of directors comply with the company law, the articles of association and other relevant provisions, and are legal and effective. We agree to appoint Ms. Kong Yun as the financial director. At the same time, it is agreed that the financial director of the company shall receive salary according to the company’s salary regulations according to his specific management positions in the company.
2、 Independent opinions on the provision for asset impairment
The company’s provision for asset impairment this time follows the principle of prudence and complies with the relevant provisions of the accounting standards for business enterprises and the actual situation of the company’s assets. The accrued financial statements can more objectively and fairly reflect the company’s asset status and operating results, and there is no damage to the legitimate rights and interests of the company and all shareholders, especially small and medium-sized shareholders. Necessary procedures have been implemented for this decision, and relevant approval and decision-making procedures are legal and compliant. We agree that the company will withdraw the provision for asset impairment this time.
(no text below)
(there is no text on this page, which is the signature page of Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) independent director’s independent opinions on relevant matters of the company) signature of independent director:
Zhu Houjia, Liu laiping, Wang Xuegong
December 30, 2001
